Gregory Scott Duncan Virios Therapeutics, Inc. (VIRI) insider trading activity

Gregory Scott Duncan is CHIEF EXECUTIVE OFFICER of Virios Therapeutics, Inc.. Currently has a direct ownership of 57,461 shares of VIRI, which is worth approximately $9,768. The most recent transaction as insider was on Aug 17, 2023, when has been sold 25,000 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $31,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.5K

0% 3M change

0% 12M change

Total Value Held $9,768

Gregory Scott Duncan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 17 2023	BUY Open market or private purchase	$31,250 $1.25 p/Share	25,000 Added 30.32%	57,461 Common Stock
May 23 2022	BUY Open market or private purchase	$33,900 $4.52 p/Share	7,500 Added 18.77%	32,461 Common Stock
Dec 21 2021	BUY Open market or private purchase	$27,600 $5.52 p/Share	5,000 Added 16.69%	24,961 Common Stock
Apr 06 2021	BUY Open market or private purchase	$2,430 $6.36 p/Share	382 Added 1.88%	19,961 Common Stock
Apr 05 2021	BUY Open market or private purchase	$96,715 $6.17 p/Share	15,675 Added 44.46%	19,579 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	$6,248 $7.8 p/Share	801 Added 17.02%	3,904 Common Stock

Also insider at

CRMD

CorMedix Inc. Healthcare

GSD